Drug · DIN 02238873
AZOPT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 14, 2018; first marketed November 11, 1998.
- Drug Identification Number (DIN)
- 02238873
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Brinzolamide S01EC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BRINZOLAMIDE | 1 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 16, 2017: NOC 18978New Drug Submission (NDS) · Transfer of drug identification number
- October 23, 1998: NOC 2710New Drug Submission (NDS)